FDA approves first new Alzheimer's disease drug in nearly 20 years

sriamerican

Well-known member
  • Aug 2, 2020
    1,723
    8,183
    113


    bFtRvv.png
     

    imhotep

    Well-known member
  • Mar 29, 2017
    14,849
    8
    35,419
    113
    There were several monoclonal antibodies on trial and this is one of them. It's sort of Passive Immunization using mAbs that can target amyloids, which in turn could delay or even halt the degeneration and thus the progression of the disease. Hope for the best. :yes: